4//SEC Filing
Spring Bank Pharmaceuticals, Inc. 4
Accession 0001209191-17-043261
CIK 0001566373operating
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:10 PM ET
Size
7.8 KB
Accession
0001209191-17-043261
Insider Transaction Report
Form 4
Eichler Kurt M
Director
Transactions
- Award
Common Stock
2017-07-03+936→ 583,469 total
Holdings
- 19,791(indirect: See footnote)
Common Stock
- 1,200(indirect: See footnote)
Common Stock
- 10,000(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Pursuant to the Issuer's Non-Employee Director Compensation Policy, the shares on this Form 4 were automatically issued to the Reporting Person, who previously elected to take shares in lieu of cash compensation for services as a director and committee member of the Issuer.
- [F2]These shares are directly held by Theresa Eichler as custodian for Katherine Eichler UGMA NJ. Teresa Eichler and Katherine Eichler are immediate family members sharing a household with the Reporting Person.
- [F3]These shares are directly held by the Kurt M. Eichler Trust Under Agreement dated 12/27/14 FBO Katherine Eichler (the "Katherine Eichler Trust"). The Reporting Person's immediate family member, Katherine Eichler, is a beneficiary of the Katherine Eichler Trust, and the Reporting Person is a trustee of the Katherine Eichler Trust.
- [F4]These shares are directly held by the Reporting Person as custodian for Katherine Eichler. Katherine Eichler is an immediate family member sharing a household with the Reporting Person.
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001566373
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 4:10 PM ET
- Size
- 7.8 KB